Clinical Trials in White Marsh, Maryland

10 recruiting

Showing 110 of 10 trials

Recruiting
Phase 3

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

Asthma
Teva Branded Pharmaceutical Products R&D, Inc.724 enrolled138 locationsNCT06664619
Recruiting
Phase 3

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

Asthma
Teva Branded Pharmaceutical Products R&D LLC2,700 enrolled393 locationsNCT06052267
Recruiting
Phase 3

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Asthma
AstraZeneca440 enrolled131 locationsNCT06307665
Recruiting
Phase 2

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

Asthma
AstraZeneca540 enrolled208 locationsNCT06932263
Recruiting
Phase 4

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma

Asthma
Sanofi1,324 enrolled250 locationsNCT05097287
Recruiting
Phase 2

A Study to Evaluate Solriktug in Adult Participants With Asthma

Asthma
Uniquity One (UNI)140 enrolled74 locationsNCT06496607
Recruiting
Phase 2

Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

Asthma (Diagnosis)
Windward Bio136 enrolled64 locationsNCT07120503
Recruiting
Phase 2

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

Severe Asthma
Upstream Bio Inc.436 enrolled84 locationsNCT06966479
Recruiting
Phase 2

Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

Asthma Acute
Connect Biopharm LLC160 enrolled46 locationsNCT06940141
Recruiting
Phase 2

A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

Chronic Obstructive Pulmonary Disease
Upstream Bio Inc.666 enrolled325 locationsNCT06981078